Obenshain Andrew 4
4 · bluebird bio, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Obenshain Andrew
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-09-30+130,000→ 409,998 total - Sale
Common Stock
2024-09-30$0.53/sh−34,780$18,270→ 375,218 total
Footnotes (3)
- [F1]These restricted stock units for common stock vest over a four-year period at the rate of 25% on each of March 1, 2025, March 1, 2026, March 1, 2027 and March 1, 2028. These restricted stock units were approved during the Issuer's regular annual review cycle for 2024 with a delayed date of issuance.
- [F2]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F3]The range in prices for the transaction reported on this line was $0.5211 to $0.5273. The average weighted price was $0.5253. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.